FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used to predict progression of chronic cardiac failure (CCF) within one year after a previous myocardial infarction. In 6 months after myocardial infarction, blood is sampled and erythrocyte beta adrenoreactivity is determined. If observing erythrocyte adrenoreactivity values – β-ARM is more than or equal to 49.53 standard units, progression of chronic cardiac failure is predicted. If observing values of β-ARM below 49.53 standard units, predicted favorable course of disease.
EFFECT: method provides more accurate prediction of CCF progression within a year after myocardial infarction by evaluating the β-ARM, which is an early predictor of CCF progression in the patients.
1 cl, 1 dwg, 1 tbl, 3 ex
